TNF-α-308G/A polymorphism contributes to obstructive sleep apnea syndrome risk: Evidence based on 10 case-control studies

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wu, Yanping ^a   Cao, Chao ^a,b   Wu, Yinfang ^a   Zhang, Chao ^a   Zhu, Chen ^a   Ying, Songmin ^a   Chen, Zhihua ^a   Shen, Huahao ^a   Li, Wen ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALLELE; ARTICLE; ASIAN; EUROPEAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; RISK FACTOR; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; TUMOR NECROSIS FACTOR ALPHA GENE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; ODDS RATIO; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907006769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106183     Document Type: Article

References (35)

1. Eckert DJ, Malhotra A (2008) Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5: 144-153.
2. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 165: 1217- 1239.
3. Hiestand DM, Britz P, Goldman M, Phillips B (2006) Prevalence of symptoms and risk of sleep apnea in the US population: Results from the national sleep foundation sleep in America 2005 poll. Chest 130: 780-786.
4. Kielb SA, Ancoli-Israel S, Rebok GW, Spira AP (2012) Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment. Neuromolecular Med 14: 180-193.
5. Krueger JM (2008) The role of cytokines in sleep regulation. Curr Pharm Des 14: 3408-3416.
6. Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28: 87-91.
7. Li NF, Yao XG, Zhu J, Yang J, Liu KJ, et al. (2010) Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 32: 54-60.
8. Zamarron C, Garcia Paz V, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19: 390-398.
9. Raabe T, Bukrinsky M, Currie RA (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273: 974-980.
10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
11. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, et al. (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113: 401-406.
12. Kroeger KM, Steer JH, Joyce DA, Abraham LJ (2000) Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12: 110-119.
13. Wilson AG, diGiovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1: 353.
14. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2010) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
15. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
17. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
19. Der-Simonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
21. Li T, Qian X, Guo R, Sun B, Liu C (2013) Relation between TNF-α polymorphism and obstructive sleep apnea syndrome accompanying hypertension. Acad J Chinese PLA Med Sch 34.
22. Guan Jian YH, Meng L, Su K, Yin S (2013) Study of association of TNF-alpha gene Polymorphism with OSAHS and metabolic syndrome Chln Arch Otolaryngol Head Neck Surg 20.
23. Karkucak M, Ursavas A, Ocakoglu G, Görükmez O, Yakut T, et al. (2012) Analysis of TNF-alpha G308A and C857T gene polymorphisms in Turkish patients with obstructive sleep apnea syndrome. Turkiye Klinikleri Journal of Medical Sciences 32: 1368-1373.
24. Almpanidou P, Hadjigeorgiou G, Gourgoulianis K, Papadimitriou A (2012) Association of tumor necrosis factor-alpha gene polymorphism (-308) and obstructive sleep apnea-hypopnea syndrome. Hippokratia 16: 217-220.
25. Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS, Gozal D (2011) TNF-alpha gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 158: 77-82.
26. Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK (2009) TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 103: 386-392.
27. Popko K, Gorska E, Potapinska O, Wasik M, Stoklosa A, et al. (2008) Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea. J Physiol Pharmacol 59 Suppl 6: 607-614.
28. Liu HG, Guan P, Lin M, Xu YJ, Zhang ZX (2006) The relationship between tumor necrosis factor-alpha gene promoter polymorphism and obstructive sleep apnea-hypopnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 29: 596-599.
29. Li F, Xue Y (2006) Tumor Necrosis Factor-A(-308)Gene And Serotonin Transporier Gene Polymorphism With Obstructive Apnea Syndrome.
30. Riha RL, Brander P, Vennelle M, McArdle N, Kerr SM, et al. (2005) Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoeahypopnoea syndrome. Eur Respir J 26: 673-678.
31. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, et al. (2000) Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 43: 117-120.
32. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, et al. (2001) Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25: 581-585.
33. Teramoto S, Yamamoto H, Ouchi Y (2003) Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 107: E40-E40.
34. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, et al. (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105: 2462-2464.
35. Huang J, Liao N, Huang QP, Xie ZF (2012) Association between tumor necrosis factor-alpha-308G/A polymorphism and obstructive sleep apnea: A metaanalysis. Genet Test Mol Biomarkers 16: 246-251.